News > Anti-viral pill 89% effective for high-risk Covid patients: Pfizer

Anti-viral pill 89% effective for high-risk Covid patients: Pfizer

The Siasat | 14/12/2021 10:16 PM | Click to read full article

Pfizer on Tuesday announced that the final analysis of Paxlovid, its antiviral pill against Covid, has shown it to be 89 per cent effective in reducing hospitalisation or death in high-risk patients.

Pfizer also released early data from a second clinical trial showing that the treatment reduced hospitalisations by around 70 per cent in around 600 standard-risk adults.